18 June 2013
Keywords: reneuron, reports, positive, early, data, ctx, pad
Article | 06 April 2009
UK stem cell firm ReNeuron has reported positive preclinical efficacy data with its lead CTX stem cell line in a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 April 2009
8 April 2009
3 April 2009
© 2013 thepharmaletter.com